Faeth Therapeutics
Faeth develops oral cancer drugs targeting multiple nodes of the PI3K/AKT/mTOR pathway for patients with endometrial and breast cancer.
Backed by Catalio Capital Management, LP, Future Ventures, Iselect Fund Management, LLC
Traction is an independent job board.
This listing is read from the company’s own careers page and links straight back to it. We never receive your application.